● COVID-19: El-Rufai, medical experts to discuss vaccines efficacy

● COVID-19: El-Rufai, medical experts to discuss vaccines efficacy

From Noah Ebije, Kaduna


Kaduna State governor, Nasir El-Rufai and a staff of medical experts drawn from numerous excessive establishments, together with United States of America (USA) are billed to discuss the efficacy of Covid-19 vaccines.

The occasion webinar, which is being organised by Sir Ahmadu Bello Memorial Foundation, will discuss the security of vaccines.

In a press release the Managing Director, Sir Ahmadu Bello Memorial Foundation, Abubakar G. Umar, stated: “The on-line seminar is meant to sensitise the public and present solutions to all the points surrounding the COVID-19 pandemic and its vaccines.

“The webinar, which comes up on Thursday with Malam Nasir Ahmed el-Rufai, the govt governor of Kaduna State as a particular visitor of honour, will function a staff of medical experts to give their opinions about the Covid-19.

“Speakers at the webinar embrace the Executive Director, National Primary Health Care Development Agency, Dr. Faisal Shu’aibu and Prof. Abdulsalam Nasidi, a pioneer epidemiologist.

“Others are Dr. Nasiru Sani Gwarzo, an epidemiologist; Permanent Secretary, Federal Ministry of Industry Trade and Investments, Prof. Zubairu Iliyasu; Director of Centre for Infectious Diseases, Bayero University Kano, Prof Sarki Abba; Director, Centre for Urologic Oncology, Northwestern University, Chicago USA, and Dr. Muhammed Adis, Executive Secretary of Nasarawa State Primary Health Care Development Agency. Members of the public are invited to join and participate at the online public seminar using the ZOOM platform.”

Don’t forget to like our page on Facebook and Follow us on Twitter for more and latest updates.

Also note that this post does not reflect the views of Nairalovers. If you feel this post violated some policies, do not hesitate to Contact us with evidence and it will be taken down. See our Declaimer for more.

Be the first to get updated. Subscribe to our newsletter

Share This Post

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Enter Captcha Here :